Thanks to the effective implementation of our research results into practice, numerous people are already benefiting from new types of medication and improved prevention. In this way, we fulfill our commitment to translational research.

In the process, the DZD focuses on the early and middle phases up to clinical phase II of the traditional pharmaceutical value chain. We lay important foundations for better prevention, more precise diagnoses and diabetes therapies. The results of our research are incorporated into medical guidelines and form the basis of patents and spin-offs.

The work of the DZD has added value for society. On the online-based national diabetes information portal diabinfo.de, we provide generally understandable and quality-assured information on prevention and treatment relating to all aspects of diabetes and its complications.